Amino acid 95 causes strong alteration of peptide position PΩ in HLA-B*41 variants

Immunogenetics

Volumn 59, Issue 4, 2007, Pages 253-259

  Bade Doeding, Christina ^a   DeLuca, David S ^a   Seltsam, Axel ^a   Blasczyk, Rainer ^a   Eiz Vesper, Britta ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

P position; Peptide binding motif; Pocket definition

Indexed keywords

AMINO ACID; ARGININE; HLA B ANTIGEN; LEUCINE; PROLINE; TRYPTOPHAN; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS; HLA-B ANTIGENS; HUMANS; PEPTIDES; PROTEIN CONFORMATION;

EID: 33847785568     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-007-0197-7     Document Type: Article

References (24)

1. Arnett KL, Huang W, Valiante NM, Barber LD, Parham P (1998) The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells. Immunogenetics 48:56-61
2. Bade-Döding C, Elsner HA, Eiz-Vesper B, Seltsam A, Holtkamp U, Blasczyk R (2004) A single amino acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared to HLA-A*6601 ligands. Immunogenetics 56:83-88
3. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, Parham P (1995) Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 5:179-190
4. Barber LD, Percival L, Arnett KL, Gumperz JE, Chen L, Parham P (1997) Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J Immunol 158:1660-1669
5. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell 14:9-20
6. Brodsky F, Parham P, Barnstable C, Crumpton M, Bodmer W (1979) Monoclonal antibodies for analysis of the HLA system. Immunol Rev 47:3-61
7. Chelvanayagam G (1996) A roadmap for HLA-A, HLA-B, HLA-C allotype peptide binding specificities. Immunogenetics 45:15-26
8. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296
9. Falk K, Rotzschke O, Takiguchi M, Gnau V, Stevanovic S, Jung G, Rammensee HG (1995) Peptide motifs of HLA-B58, B60, B61, and B62 molecules. Immunogenetics 41:165-168
10. Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC (1989) Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692-696
11. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis 18:2714-2723
12. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR, McCluskey J, Rossjohn J (2003) A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18:53-64
13. Li AJ, Nussinov R (1998) A set of van der Waals and coulombic radii of protein atoms for molecular and solvent-accessible surface calculation, packing evaluation, and docking. Proteins 32:111-127
14. Li L, Bouvier M (2004) Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. J Immunol 172:6175-6184
15. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, Worning P, Sylvester-Hvid C, Lamberth K, Roder G, Justesen S, Buus S, Brunak S (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55:797-810
16. Maier R, Falk K, Rotzschke O, Maier B, Gnau V, Stevanovic S, Jung G, Rammensee HG, Meyerhans A (1994) Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40:306-308
17. Matsumura M, Fremont DH, Peterson PA, Wilson IA (1992) Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927-934
18. Reid SW, McAdam S, Smith KJ, Klenerman P, O'Callaghan CA, Harlos K, Jakobsen BK, McMichael AJ, Bell JI, Stuart DI, Jones EY (1996) Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 184:2279-2286
19. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 219:277-319
20. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31:3381-3385
21. Scotet E, David-Ameline J, Peyrat MA, Moreau-Aubry A, Pinczon D, Lim A, Even J, Semana G, Berthelot JM, Breathnach R, Bonneville M, Houssaint E (1996) T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 184:1791-1800
22. Smith KD, Epperson DF, Lutz CT (1996) Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation. Immunogenetics 43:27-37
23. Sudo T, Kamikawaji N, Kimura A, Date Y, Savoie CJ, Nakashima H, Furuichi E, Kuhara S, Sasazuki T (1995) Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol 155:4749-4756
24. Zhao B, Png AE, Ren EC, Kolatkar PR, Mathura VS, Sakharkar MK, Kangueane P (2003) Compression of functional space in HLA-A sequence diversity. Hum Immunol 64:718-728